Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 3/20 | 0.30 |
| ▸ | PPARA | Q07869 | 3/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19544820 | 0.90 | HDAC8 (0.35) | MCL1ACMSDHDAC8HDAC6PPARG | |
| SCHEMBL19544819 | 0.79 | CYP2C9 (0.39) | MCL1ACMSDHDAC8HDAC6PPARG | |
| SCHEMBL22671714 | 0.77 | GPR84 (0.31) | GPR84 | |
| SCHEMBL22671622 | 0.75 | PPARG (0.33) | MCL1ACMSDHDAC8HDAC6PPARG | |
| SCHEMBL23078267 | 0.74 | ALDH1A1 (0.32) | MCL1ACMSD | |
| SCHEMBL24570798 | 0.74 | — | — | |
| SCHEMBL27437055 | 0.72 | ALOX5 (0.31) | — | |
| SCHEMBL22756960 | 0.72 | — | — | |
| SCHEMBL25653846 | 0.72 | GPR84 (0.37) | GPR84 | |
| SCHEMBL13367612 | 0.72 | ENPP3 (0.40) | MCL1ACMSDHDAC8HDAC6GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | EML4, EBPL, LEF1 | MCL1 3295/4885ACMSD 1306/4885HDAC8 3603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.